LOADING
Comparing Thermo Fisher Scientific (TMO) and Nike Inc (NKE) across the Health Care and Consumer Discretionary sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | TMO | NKE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $232.7B | -- |
| P/E Ratio | 33.8 | -- |
| Forward P/E | 24.4 | -- |
| PEG Ratio | 2.00 | -- |
| EPS | $18.63 | -- |
| Revenue Growth (YoY) | 10.5% | -- |
| Profit Margin | 15.0% | -- |
| Return on Equity | 13.5% | -- |
| Dividend Yield | 0.29% | -- |
| Beta | 0.85 | -- |
| 52-Week High | $642.71 | -- |
| 52-Week Low | $434.83 | -- |
| Volume | -- | -- |